Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity

Benjamin H. Natelson, Xiangling Mao, Aaron J. Stegner, Gudrun Lange, Diana Vu, Michelle Blate, Guoxin Kang, Eli Soto, Tolga Kapusuz, Dikoma C. Shungu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The purpose of this study was to investigate whether CFS patients without comorbid psychiatric diagnoses differ from CFS patients with comorbid psychiatric diagnoses and healthy control subjects in neuropsychological performance, the proportion with elevated spinal fluid protein or white cell counts, cerebral blood flow (CBF), brain ventricular lactate and cortical glutathione (GSH). The results of the study did not show any differences in any of the outcome measures between CFS patients with and without psychiatric comorbidity, thus indicating that psychiatric status may not be an exacerbating factor in CFS. Importantly, significant differences were found between the pooled samples of CFS compared to controls. These included lower GSH and CBF and higher ventricular lactate and rates of spinal fluid abnormalities in CFS patients compared to healthy controls. Thirteen of 26 patients had abnormal values on two or more of these 4 brain-related variables. These findings, which replicate the results of several of our prior studies, support the presence of a number of neurobiological and spinal fluid abnormalities in CFS. These results will lead to further investigation into objective biomarkers of the disorder to advance the understanding of CFS.

Original languageEnglish (US)
Pages (from-to)411-416
Number of pages6
JournalJournal of the Neurological Sciences
Volume375
DOIs
StatePublished - Apr 15 2017
Externally publishedYes

Fingerprint

Chronic Fatigue Syndrome
Psychiatry
Comorbidity
Cerebrovascular Circulation
Brain
Mental Disorders
Lactic Acid
Glutathione
Healthy Volunteers
Cell Count
Biomarkers
Outcome Assessment (Health Care)
Proteins

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity. / Natelson, Benjamin H.; Mao, Xiangling; Stegner, Aaron J.; Lange, Gudrun; Vu, Diana; Blate, Michelle; Kang, Guoxin; Soto, Eli; Kapusuz, Tolga; Shungu, Dikoma C.

In: Journal of the Neurological Sciences, Vol. 375, 15.04.2017, p. 411-416.

Research output: Contribution to journalArticle

Natelson, Benjamin H. ; Mao, Xiangling ; Stegner, Aaron J. ; Lange, Gudrun ; Vu, Diana ; Blate, Michelle ; Kang, Guoxin ; Soto, Eli ; Kapusuz, Tolga ; Shungu, Dikoma C. / Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity. In: Journal of the Neurological Sciences. 2017 ; Vol. 375. pp. 411-416.
@article{19fe874d5f634fe1a9e5945f4b944de1,
title = "Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity",
abstract = "The purpose of this study was to investigate whether CFS patients without comorbid psychiatric diagnoses differ from CFS patients with comorbid psychiatric diagnoses and healthy control subjects in neuropsychological performance, the proportion with elevated spinal fluid protein or white cell counts, cerebral blood flow (CBF), brain ventricular lactate and cortical glutathione (GSH). The results of the study did not show any differences in any of the outcome measures between CFS patients with and without psychiatric comorbidity, thus indicating that psychiatric status may not be an exacerbating factor in CFS. Importantly, significant differences were found between the pooled samples of CFS compared to controls. These included lower GSH and CBF and higher ventricular lactate and rates of spinal fluid abnormalities in CFS patients compared to healthy controls. Thirteen of 26 patients had abnormal values on two or more of these 4 brain-related variables. These findings, which replicate the results of several of our prior studies, support the presence of a number of neurobiological and spinal fluid abnormalities in CFS. These results will lead to further investigation into objective biomarkers of the disorder to advance the understanding of CFS.",
author = "Natelson, {Benjamin H.} and Xiangling Mao and Stegner, {Aaron J.} and Gudrun Lange and Diana Vu and Michelle Blate and Guoxin Kang and Eli Soto and Tolga Kapusuz and Shungu, {Dikoma C.}",
year = "2017",
month = "4",
day = "15",
doi = "10.1016/j.jns.2017.02.046",
language = "English (US)",
volume = "375",
pages = "411--416",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity

AU - Natelson, Benjamin H.

AU - Mao, Xiangling

AU - Stegner, Aaron J.

AU - Lange, Gudrun

AU - Vu, Diana

AU - Blate, Michelle

AU - Kang, Guoxin

AU - Soto, Eli

AU - Kapusuz, Tolga

AU - Shungu, Dikoma C.

PY - 2017/4/15

Y1 - 2017/4/15

N2 - The purpose of this study was to investigate whether CFS patients without comorbid psychiatric diagnoses differ from CFS patients with comorbid psychiatric diagnoses and healthy control subjects in neuropsychological performance, the proportion with elevated spinal fluid protein or white cell counts, cerebral blood flow (CBF), brain ventricular lactate and cortical glutathione (GSH). The results of the study did not show any differences in any of the outcome measures between CFS patients with and without psychiatric comorbidity, thus indicating that psychiatric status may not be an exacerbating factor in CFS. Importantly, significant differences were found between the pooled samples of CFS compared to controls. These included lower GSH and CBF and higher ventricular lactate and rates of spinal fluid abnormalities in CFS patients compared to healthy controls. Thirteen of 26 patients had abnormal values on two or more of these 4 brain-related variables. These findings, which replicate the results of several of our prior studies, support the presence of a number of neurobiological and spinal fluid abnormalities in CFS. These results will lead to further investigation into objective biomarkers of the disorder to advance the understanding of CFS.

AB - The purpose of this study was to investigate whether CFS patients without comorbid psychiatric diagnoses differ from CFS patients with comorbid psychiatric diagnoses and healthy control subjects in neuropsychological performance, the proportion with elevated spinal fluid protein or white cell counts, cerebral blood flow (CBF), brain ventricular lactate and cortical glutathione (GSH). The results of the study did not show any differences in any of the outcome measures between CFS patients with and without psychiatric comorbidity, thus indicating that psychiatric status may not be an exacerbating factor in CFS. Importantly, significant differences were found between the pooled samples of CFS compared to controls. These included lower GSH and CBF and higher ventricular lactate and rates of spinal fluid abnormalities in CFS patients compared to healthy controls. Thirteen of 26 patients had abnormal values on two or more of these 4 brain-related variables. These findings, which replicate the results of several of our prior studies, support the presence of a number of neurobiological and spinal fluid abnormalities in CFS. These results will lead to further investigation into objective biomarkers of the disorder to advance the understanding of CFS.

UR - http://www.scopus.com/inward/record.url?scp=85014087738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014087738&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2017.02.046

DO - 10.1016/j.jns.2017.02.046

M3 - Article

VL - 375

SP - 411

EP - 416

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

ER -